Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy - CardioMET Registry

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Inclusion Criteria:

• Age ≥ 18 years;
• Diagnosis of type 2 diabetes mellitus (T2DM);
• Stable clinical conditions
• Outpatient settings
• Ability to understand the study procedures and provide written informed consent.

Exclusion Criteria:

• Patients with type 1 diabetes mellitus;
• Active participation in interventional studies;
• Any condition that may put the patient at risk by participating in the study.